Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jazz Pharmaceuticals (JAZZ)
NASDAQ:JAZZ
Jazz Pharmaceuticals (JAZZ) Stock Forecast & Price Target
1,418 Followers
See the Price Targets and Ratings of:
JAZZ Analyst Ratings
Strong Buy
12 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
JAZZ Stock 12 Month Forecast
Average Price Target
$178.67
▲(70.02% Upside)
| Highest Price Target$230.00 | Average Price Target$178.67 | Lowest Price Target$113.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Bank of America Securities
Reiterated
06/20/24
Goldman Sachs
Initiated
06/05/24
Robert W. Baird
Reiterated
06/03/24
Stifel Nicolaus
Reiterated
06/03/24
Leerink Partners
―
Buy
―
Reiterated
05/23/24
We continue to believe that HER2+ BTC will be a nice niche opportunity for zani while acknowledging that this is an active space with competition, and we remain Outperform.
H.C. Wainwright
$200
Buy
90.31%
Upside
Reiterated
05/03/24
Analysts Offer Insights on Healthcare Companies: Kronos Bio (NASDAQ: KRON), Jazz Pharmaceuticals (NASDAQ: JAZZ) and KalVista Pharmaceuticals (NASDAQ: KALV)
Truist Financial
―
Buy
―
Reiterated
05/02/24
Truist Financial Keeps Their Buy Rating on Jazz Pharmaceuticals (JAZZ)
Morgan Stanley
$165→$160
Hold
52.25%
Upside
Reiterated
05/02/24
Jazz Pharmaceuticals (JAZZ) PT Lowered to $160 at Morgan StanleyMorgan Stanley analyst Jeffrey Hung lowered the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $160.00 (from $165.00) while maintaining a Equalweight rating.
J.P. Morgan
$170→$190
Buy
80.80%
Upside
Reiterated
03/25/24
Jazz Pharmaceuticals (JAZZ) PT Raised to $190 at JPMorganJPMorgan analyst Jessica Fye raised the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $190.00 (from $170.00) while maintaining a Overweight rating.
Best Analysts Covering Jazz Pharmaceuticals
Which Analyst Should I Follow If I Want to Buy JAZZ and Sell After:
1 Month
3 Months
1 Year
Success Rate
11/22 ratings generated profit
Average Return
+2.33%
reiterated a buy rating last month
Copying Annabel Samimy's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +2.33% per trade.
2 Years
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
JAZZ Analyst Recommendation Trends
Rating
Mar 24
Apr 24
May 24
Jun 24
Jul 24
Strong Buy
18
18
21
19
17
Buy
11
8
7
4
4
Hold
3
3
4
2
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
32
29
32
25
24
Each month's total comprises the sum of three months' worth of ratings.
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
JAZZ Financial Forecast
JAZZ Stock Forecast FAQ
What is JAZZ’s average 12-month price target, according to analysts?
Based on analyst ratings, Jazz Pharmaceuticals’s 12-month average price target is $178.67.
What is JAZZ’s upside potential, based on the analysts’ average price target?
Jazz Pharmaceuticals has 70.02% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is JAZZ a Buy, Sell or Hold?
Jazz Pharmaceuticals has a consensus rating of Strong Buy which is based on 12 buy ratings, 2 hold ratings and 0 sell ratings.
What is Jazz Pharmaceuticals’s price target?
The average price target for Jazz Pharmaceuticals is $178.67. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $230.00 ,the lowest forecast is $113.00. The average price target represents 70.02% Increase from the current price of $105.09.
The highest analyst price target is $230.00 ,the lowest forecast is $113.00. The average price target represents 70.02% Increase from the current price of $105.09.
What do analysts say about Jazz Pharmaceuticals?
Jazz Pharmaceuticals’s analyst rating consensus is a Strong Buy. This is based on the ratings of 14 Wall Streets Analysts.
How can I buy shares of JAZZ?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.